Semaglutide and Risk of Pancreatic Cancer: A Meta-Analysis of Randomised Trials.

Saved in:
Bibliographic Details
Title: Semaglutide and Risk of Pancreatic Cancer: A Meta-Analysis of Randomised Trials.
Authors: Chiang CH; Northwell Health Cancer Institute, New Hyde Park, New York, USA., Bahar F; Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, Massachusetts, USA., Chang YC; Department of Medicine, Danbury Hospital, Danbury, Connecticut, USA., Wang TH; Department of Medicine, University at Buffalo-Catholic Health System, Buffalo, New York, USA., Hsia YP; Department of Family Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan., Chiang CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2026 Jun 15. Date of Electronic Publication: 2026 Jun 15.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1463-1326
DOI:10.1111/dom.70980